Mayasah Y. Nema-Al

Kuala Lumpur, 56000, Malaysia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Structural insight into the lead identification of a dual inhibitor of PDE1B and PDE10A: Integrating pharmacophore-based virtual screening, molecular docking, and structure-activity-relationship approaches.

Structural insight into the lead identification of a dual inhibitor of PDE1B and PDE10A: Integrating pharmacophore-based virtual screening, molecular docking, and structure-activity-relationship approaches.

Journal: Heliyon

Published: December 18, 2023

Designing of 2,3-dihydrobenzofuran derivatives as inhibitors of PDE1B using pharmacophore screening, ensemble docking and molecular dynamics approach.

Designing of 2,3-dihydrobenzofuran derivatives as inhibitors of PDE1B using pharmacophore screening, ensemble docking and molecular dynamics approach.

Journal: Computers in biology and medicine

Published: September 02, 2022

Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases.

Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases.

Journal: Current topics in medicinal chemistry

Published: May 02, 2022

Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia.

Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia.

Journal: PloS one

Published: March 26, 2022

Structure-based discovery and bio-evaluation of a cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one as a phosphodiesterase 10A inhibitor.

Structure-based discovery and bio-evaluation of a cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one as a phosphodiesterase 10A inhibitor.

Journal: RSC advances

Published: October 15, 2021

Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor.

Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor.

Journal: Heliyon

Published: May 17, 2020

Phosphodiesterase as a Target for Cognition Enhancement in Schizophrenia.

Phosphodiesterase as a Target for Cognition Enhancement in Schizophrenia.

Journal: Current topics in medicinal chemistry

Published: March 12, 2020

Protein-Protein Interactions of Phosphodiesterases.

Protein-Protein Interactions of Phosphodiesterases.

Journal: Current topics in medicinal chemistry

Published: August 06, 2018

Discovery of natural product inhibitors of phosphodiesterase 10A as novel therapeutic drug for schizophrenia using a multistep virtual screening.

Discovery of natural product inhibitors of phosphodiesterase 10A as novel therapeutic drug for schizophrenia using a multistep virtual screening.

Journal: Computational biology and chemistry

Published: June 20, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026